We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$98.7B
AUM Growth
-$13.4B
Cap. Flow
+$3.55B
Cap. Flow %
3.6%
Top 10 Hldgs %
17.21%
Holding
8,079
New
273
Increased
3,486
Reduced
3,341
Closed
357

Sector Composition

Rank Sector Weight
1 Technology 5.78%
2 Financials 5.08%
3 Healthcare 4.24%
4 Consumer Discretionary 4.16%
5 Energy 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CC icon
2576
CALL
Chemours
CC
$2.57B
$2.13M ﹤0.01%
75,300
-26,300
-26% -$832K
NVR icon
2577
NVR
NVR
$16.8B
$2.13M ﹤0.01%
872
-890
-51% -$2.1M
KNX icon
2578
Knight Transportation
KNX
$11.3B
$2.12M ﹤0.01%
84,590
-2,917
-3% -$90.3K
HSIC icon
2579
PUT
Henry Schein
HSIC
$9.7B
$2.12M ﹤0.01%
34,425
+18,615
+118% +$1.23M
LABU icon
2580
PUT
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$553M
$2.12M ﹤0.01%
3,225
+2,400
+291% +$2.52M
CCJ icon
2581
CALL
Cameco
CCJ
$38.4B
$2.12M ﹤0.01%
186,900
+31,300
+20% +$362K
SRNE
2582
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$2.11M ﹤0.01%
880,598
+554,869
+170% +$1.81M
PZZA icon
2583
Papa John's
PZZA
$995M
$2.11M ﹤0.01%
53,023
+29,211
+123% +$1.47M
PCRX icon
2584
Pacira BioSciences
PCRX
$1.06B
$2.11M ﹤0.01%
49,068
-4,348
-8% -$203K
BPYU
2585
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$2.11M ﹤0.01%
131,005
-6,118
-4% -$112K
IFF icon
2586
PUT
International Flavors & Fragrances
IFF
$20.3B
$2.11M ﹤0.01%
15,700
+10,000
+175% +$1.38M
NDAQ icon
2587
Nasdaq
NDAQ
$53.2B
$2.11M ﹤0.01%
77,562
-151,224
-66% -$4.31M
TTD icon
2588
Trade Desk
TTD
$8.59B
$2.11M ﹤0.01%
181,540
-12,200
-6% -$153K
SCU
2589
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$2.1M ﹤0.01%
228,404
-5,102
-2% -$62.1K
SBH icon
2590
Sally Beauty Holdings
SBH
$1.46B
$2.1M ﹤0.01%
123,133
+9,561
+8% +$179K
VSS icon
2591
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
$2.1M ﹤0.01%
22,184
+2,814
+15% +$285K
HUBB icon
2592
Hubbell
HUBB
$25B
$2.1M ﹤0.01%
21,129
-28,924
-58% -$3.17M
OKTA icon
2593
PUT
Okta
OKTA
$24.4B
$2.1M ﹤0.01%
32,900
-76,800
-70% -$4.55M
CALY
2594
Callaway Golf Company
CALY
$3.33B
$2.09M ﹤0.01%
136,782
+77,407
+130% +$1.55M
NUAN
2595
DELISTED
Nuance Communications, Inc.
NUAN
$2.09M ﹤0.01%
182,562
-39,937
-18% -$559K
TGTX icon
2596
TG Therapeutics
TGTX
$8.19B
$2.08M ﹤0.01%
507,973
+336,978
+197% +$1.67M
NVTA
2597
DELISTED
Invitae Corporation
NVTA
$2.08M ﹤0.01%
188,255
+162,792
+639% +$2.11M
CGC
2598
CALL
Canopy Growth
CGC
$388M
$2.08M ﹤0.01%
7,760
+1,710
+28% +$642K
MMSI icon
2599
Merit Medical Systems
MMSI
$4.97B
$2.08M ﹤0.01%
37,164
+13,558
+57% +$806K
TTM
2600
PUT
DELISTED
Tata Motors Limited
TTM
$2.08M ﹤0.01%
170,400
+82,900
+95% +$1.04M

Similar funds

Citigroup's Q4 2018 Portfolio in Review

As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.

  • Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
  • Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
  • Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
  • Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
  • Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
  • Citigroup opened 273 new positions and closed 357 in Q4 2018.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.

Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.